Literature DB >> 12175551

Synthesis and cytotoxicity of the dihydrated complex of oxaliplatin.

Pernilla Videhult1, Jeffrey Yachnin, Elin Jerremalm, Rolf Lewensohn, Hans Ehrsson.   

Abstract

A new way of synthesizing the dihydrated oxaliplatin complex (DOC) is presented and its cytotoxicity is compared to that of oxaliplatin and cisplatin. By hydrolyzing oxaliplatin in aqueous sodium hydroxide at 70 degrees C, DOC was formed in less than 1 h. Cytotoxicity was studied in the non-small cell lung cancer cell line A549 using the fluorescent microculture cytotoxic assay. Oxaliplatin and cisplatin had similar cytotoxicity profiles, whereas DOC was found to be considerably more toxic. The cytotoxicity of oxaliplatin might, at least in part, be mediated through the formation of DOC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175551     DOI: 10.1016/s0304-3835(02)00002-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines.

Authors:  Jonathan F Arambula; Jonathan L Sessler; Mark E Fountain; Wen-hao Wei; Darren Magda; Zahid H Siddik
Journal:  Dalton Trans       Date:  2009-10-07       Impact factor: 4.390

2.  Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

Authors:  Elin Jerremalm; Mikael Hedeland; Inger Wallin; Ulf Bondesson; Hans Ehrsson
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

3.  Regulating A549 cells growth by ASO inhibiting miRNA expression.

Authors:  Ping-Yu Wang; You-Jie Li; Shuai Zhang; Zun-Ling Li; Zhen Yue; Ning Xie; Shu-Yang Xie
Journal:  Mol Cell Biochem       Date:  2010-01-05       Impact factor: 3.396

4.  The hybrid models, containing hydrolytic and electron-driven processes, in theoretical study of oxaliplatin biotransformation.

Authors:  Janina Kuduk-Jaworska; Jerzy J Jański; Szczepan Roszak
Journal:  J Mol Model       Date:  2020-09-26       Impact factor: 1.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.